Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Acq. announced Quarterly results Consulting agrmnt Appointed director
|
|
VYCOR MEDICAL INC (VYCO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/27/2020 |
8-K
| Quarterly results |
| 03/29/2019 |
8-K
| Quarterly results |
| 03/30/2018 |
8-K
| Quarterly results |
| 11/13/2017 |
8-K
| Quarterly results |
| 05/11/2017 |
8-K
| Form 8-K - Current report |
| 03/31/2017 |
8-K
| Form 8-K - Current report |
| 11/14/2016 |
8-K
| Form 8-K - Current report |
| 08/09/2016 |
8-K
| Form 8-K - Current report |
| 04/28/2016 |
8-K
| Form 8-K - Current report |
| 03/30/2016 |
8-K
| Quarterly results |
| 11/13/2015 |
8-K
| Quarterly results |
| 08/14/2015 |
8-K
| Quarterly results|
Docs:
|
"Vycor Medical Releases Financial Results for the three and six months ended June 30st, 2015 BOCA RATON, FL – Vycor Medical, Inc. , a provider of innovative and superior surgical and therapeutic solutions, reported financial results for the second quarter and first half ended June 30, 2015. Operational Highlights NovaVision ● Launched NovaVision’s new Internet-delivered therapy suite in the U.S. This therapy suite consists of two highly complementary therapies: Vision Restoration Therapy , the only FDA-approved medical therapy aimed at the restoration of vision lost as a result of neurological damage, and NeuroEyeCoach, an eye-movement compensation therapy. The suite is delivered directly to patients’ computers over the Internet. ● Expanded its agreement with HealthSouth, one of..." |
|
| 05/15/2015 |
8-K
| Quarterly results |
| 03/31/2015 |
8-K
| Quarterly results |
| 11/12/2014 |
8-K
| Quarterly results |
| 08/12/2014 |
8-K
| Quarterly results |
| 05/19/2014 |
8-K
| Quarterly results |
| 04/03/2012 |
8-K
| Form 8-K - Current report |
|
|